Cambridge Cognition’s CANTAB leveraged in landmark brain health study

CAMBRIDGE, UK - Cambridge Cognition Holdings (LON:COGC) PLC (AIM: COG), a developer of digital solutions for brain health assessment, has announced its significant involvement in one of the largest brain health studies to date, the Intuition Brain Health study. The study utilized the company’s CANTAB platform in a large-scale evaluation of cognitive function using mobile technology.

The Intuition Brain Health study, published in Nature Medicine on March 4, 2025, was sponsored by Biogen (NASDAQ:BIIB), Inc. and Apple (NASDAQ:AAPL), Inc. It included a diverse group of 23,004 participants from across the United States. Cambridge Cognition’s CANTAB platform was central to the cognitive assessment process, showcasing the platform’s capability for unsupervised digital cognitive testing on a massive scale.

Rob Baker, Joint Managing Director and Chief Operating Officer of Cambridge Cognition, stated, "The Intuition study powerfully validates CANTAB’s accuracy at scale and reinforces our leadership in digital brain health." He emphasized the importance of digital solutions in healthcare and the company’s readiness to meet this growing demand.

The study’s findings underscore the scalability and accessibility of the CANTAB platform, demonstrating its ability to conduct widespread brain health monitoring. The technology’s sensitivity in identifying mild cognitive impairment (MCI) was also highlighted, reinforcing Cambridge Cognition’s position in cognitive assessment.

Cambridge Cognition views the results of the Intuition Brain Health study as a confirmation of its role as a preferred partner in the field and as a leader in the evolution of brain health assessments. The company plans to further evaluate the commercial potential for its cognitive assessment software in real-world applications for brain health monitoring.

This involvement in the Intuition Brain Health study represents a strategic opportunity for Cambridge Cognition to expand the reach of its digital cognitive assessment tools. The study’s outcomes could pave the way for more accessible and widespread monitoring of brain health, benefiting populations across the lifespan.

The information in this article is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.